Ayala Pharmaceuticals Margine di profitto
Cos'è Margine di profitto di Ayala Pharmaceuticals?
Margine di profitto di Ayala Pharmaceuticals Inc. è -2,316.60%
Qual è la definizione di Margine di profitto?
Il margine di profitto è una misura della redditività e viene calcolato rilevando l'utile netto come percentuale delle entrate.
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Margine di profitto di aziende nel Health Care settore su NASDAQ rispetto a Ayala Pharmaceuticals
Cosa fa Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Aziende con margine di profitto simili a Ayala Pharmaceuticals
- Silver Mines ha Margine di profitto di -2,389.53%
- Protean ha Margine di profitto di -2,385.00%
- Redbank Copper ha Margine di profitto di -2,375.00%
- Cobalt Blue ha Margine di profitto di -2,347.64%
- Stanrose Mafatlal Investments and Finance ha Margine di profitto di -2,340.24%
- 4Dx ha Margine di profitto di -2,332.63%
- Ayala Pharmaceuticals ha Margine di profitto di -2,316.60%
- HTC Purenergy ha Margine di profitto di -2,315.07%
- Delcath Systems ha Margine di profitto di -2,314.56%
- Delcath Systems ha Margine di profitto di -2,308.86%
- Theranexus SA ha Margine di profitto di -2,307.43%
- Infinity Lithium ha Margine di profitto di -2,296.51%
- Vitalibis ha Margine di profitto di -2,283.33%